Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Narragansett Electric $500 million senior notes offering
We advised the company on the transaction
Borse Dubai $1.8 billion secondary offering of Nasdaq shares
We advised Borse Dubai on the offering
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Tianfeng Securities $40 million tap notes offering
We advised Tianfeng Securities on the tap notes offering
Lumen Technologies comprehensive debt recapitalization transaction
We advised an ad hoc group of noteholders and term loan lenders on the transaction
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
JPMorgan Chase €2 billion notes offering
We advised JPMorgan Chase on the euro notes offering
Banco Santander México $900 million subordinated preferred capital securities
We advised Banco Santander México on its private placement of Tier 2 capital notes
Morgan Stanley €5 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Campbell Soup $2.5 billion senior notes offering
The investment-grade notes are due 2026, 2027, 2029 and 2034